IN8bio Q4 EPS $(0.22) Misses $(0.14) Estimate
Portfolio Pulse from Happy Mohamed
IN8bio (NASDAQ:INAB) reported Q4 losses of $(0.22) per share, missing the consensus estimate of $(0.14) by 57.14%. This represents a 31.25% improvement over the $(0.32) per share loss from the same period last year.
March 14, 2024 | 8:01 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
IN8bio reported a larger than expected Q4 loss of $(0.22) per share, missing the $(0.14) estimate but improved from last year's $(0.32) loss.
The reported earnings miss is likely to negatively impact investor sentiment in the short term, as the loss was significantly larger than expected. However, the improvement from the previous year's loss may provide some mitigating effect.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100